Skip to content
Seoul Rosacea

Rosacea explained for visitors to Seoul

MenuClose

Rosacea treatment options, feature by feature

Rosacea is treated feature by feature. Ivermectin, azelaic acid or metronidazole creams and low-dose doxycycline treat bumps; brimonidine gel or oxymetazoline cream fade persistent redness for several hours; vascular lasers and intense pulsed light treat lasting redness and visible vessels. People with several features often combine treatments.[1][2]

Unlabeled cream tubes, a shallow dish of round tablets and a soft beam of light on a rose background

Written by the Seoul Rosacea editorial team and medically reviewed by a Korean Board-Certified Dermatologist (AAD International Fellow · ASLMS member). Last reviewed: .

How do dermatologists choose a rosacea treatment?

Two expert groups set the reference recommendations: the international ROSCO panel and the US National Rosacea Society committee. Both match treatment to the features in front of them rather than to a subtype label.[2][3] Each feature has first-line options. If one has not worked after a fair trial, the next step is another first-line option or an added one, and maintenance depends on the treatment and on what the patient prefers.[1]

The 2019 ROSCO update set the goal as clear skin rather than almost clear, because full clearance of bumps and redness can delay relapse.[2]

Certainty of evidence by feature, from a 2019 systematic review of 152 randomised trials with 20,944 participants
FeatureTreatmentCertainty of evidence
Persistent redness (temporary fading)Brimonidine gelHigh
Persistent redness (temporary fading)Oxymetazoline creamModerate
Redness and visible vesselsVascular laser, intense pulsed lightLow to moderate
Papules and pustulesAzelaic acid, ivermectin creamHigh
Papules and pustulesDoxycycline 40 mg modified release, isotretinoinModerate to high
Papules and pustulesMetronidazole, topical minocyclineModerate
EyesOral omega-3 fatty acidsModerate
EyesCiclosporin eye emulsion, doxycyclineLow

Source for the table: the GRADE assessments in the updated systematic review.[4]

Three lanes linking a rose wash, small domes and branching lines to a droplet, a shield and a beam of light
Each rosacea feature has its own first-line options.

Which creams treat rosacea bumps and pustules?

Ivermectin 1% cream is applied once a day. In a 16-week trial of 962 people, it reduced inflammatory lesions by 83.0% against 73.7% for twice-daily metronidazole 0.75% cream, and 84.9% against 75.4% were rated clear or almost clear.[5] Its US prescribing information lists it for the inflammatory lesions of rosacea (DailyMed label, checked 18 October 2026).

Azelaic acid (gel, foam or cream) has high-certainty evidence for bumps, and metronidazole (cream, gel or lotion) has moderate-certainty evidence.[4] Creams take time: the AAD describes a slight improvement after 3 or 4 weeks and a noticeable difference after 2 to 3 months (AAD, checked 18 October 2026).

Which creams reduce rosacea redness?

Brimonidine 0.33% gel and oxymetazoline 1% cream narrow small facial vessels. Their US labels cover persistent facial redness of rosacea in adults (brimonidine label, oxymetazoline label, both checked 18 October 2026). The AAD notes that the effect lasts up to 12 hours and peaks 3 to 6 hours after application. They reduce redness temporarily and do not remove visible vessels. The brimonidine label also warns that redness can return worse than before as the effect wears off, and that flushing can become more frequent.

Which tablets are used for rosacea?

Doxycycline 40 mg modified release is taken once daily, on an empty stomach in the morning. Its US label limits it to papules and pustules and states that no meaningful effect was shown on general redness (DailyMed label, checked 18 October 2026). The AAD describes it as a non-antibiotic dose that can be used long term, while full-dose antibiotics are kept to the shortest course possible.

Low-dose isotretinoin is used off-label, under specialist supervision, for bumps that resist other treatment; the AAD describes it as approved for severe acne. In a placebo-controlled trial of 156 patients, 0.25 mg/kg a day for four months cleared at least 90% of lesions in 57.4% of patients, against 10.4% on placebo. Rosacea returned in 58.3% of those followed for four more months, after a median of 15 weeks.[6] Isotretinoin causes birth defects, so it requires reliable contraception and is never taken in pregnancy.

Which procedures treat rosacea?

  • Vascular lasers and intense pulsed light for persistent redness and visible vessels. See lasers and light for rosacea.
  • Thickened nose skin (rhinophyma) can be reduced by a dermatologist or plastic surgeon, as the British Association of Dermatologists notes. Isotretinoin can keep the skin from thickening further but cannot remove it, according to the AAD.
  • Eye involvement is treated with lid hygiene and artificial tears plus medication, and referral to an eye specialist is advised for all but the mildest cases.[1]

Which rosacea medicines are registered in Korea?

We searched the Korean Ministry of Food and Drug Safety (MFDS) drug database on 18 October 2026 (MFDS drug search). Ivermectin 1% cream (Soolantra record) is a prescription medicine approved for inflammatory lesions of rosacea in adults. Metronidazole 0.75% gel (Rozex record) is a registered prescription medicine. Azelaic acid 20% cream (Azelia record) is registered for acne, so its use for rosacea in Korea is off-label. A product-name search for brimonidine returned only eye drops and one for oxymetazoline only nasal products, so if you use either on your skin, bring enough from home.

What does long-term rosacea management look like?

Rosacea is a chronic disease that needs long-term management and regular review of tolerability, cost and results.[2] Once the skin is under control, a dermatologist may switch to a lighter maintenance plan, while skincare, sun protection and trigger control continue. The ROSCO panel ties maintenance to the type of treatment and to what the patient prefers.[1]

A flowing line that begins as tall choppy waves and settles into a low steady ripple
From clearing flares to steady maintenance.

How long does rosacea treatment take to work?

Redness creams act within hours. Creams for bumps show a slight change in 3 to 4 weeks and a clear difference in 2 to 3 months. Laser and light treatments usually need a series of sessions.

Can I stop treatment when my skin is clear?

Ask your dermatologist before stopping. Rosacea is chronic, and the AAD describes moving to a maintenance plan once it is under control; what that plan contains depends on the treatment that cleared it.

Is doxycycline 40 mg an antibiotic course?

It is doxycycline, but at a dose the AAD calls non-antibiotic, aimed at inflammation. Its label states that it is not for treating infections.

References

Bibliographic records retrieved from PubMed (U.S. National Library of Medicine).

  1. Schaller M, Almeida LM, Bewley A, Cribier B, Dlova NC, Kautz G, et al. Rosacea treatment update: recommendations from the global ROSacea COnsensus (ROSCO) panel. Br J Dermatol. 176(2):465-471. PubMed: 27861741
  2. Schaller M, Almeida LMC, Bewley A, Cribier B, Del Rosso J, Dlova NC, et al. Recommendations for rosacea diagnosis, classification and management: update from the global ROSacea COnsensus 2019 panel. Br J Dermatol. 182(5):1269-1276. PubMed: 31392722
  3. Thiboutot D, Anderson R, Cook-Bolden F, Draelos Z, Gallo RL, Granstein RD, et al. Standard management options for rosacea: The 2019 update by the National Rosacea Society Expert Committee. J Am Acad Dermatol. 82(6):1501-1510. PubMed: 32035944
  4. van Zuuren EJ, Fedorowicz Z, Tan J, van der Linden MMD, Arents BWM, Carter B, Charland L. Interventions for rosacea based on the phenotype approach: an updated systematic review including GRADE assessments. Br J Dermatol. 181(1):65-79. PubMed: 30585305
  5. Taieb A, Ortonne JP, Ruzicka T, Roszkiewicz J, Berth-Jones J, Peirone MH, et al. Superiority of ivermectin 1% cream over metronidazole 0·75% cream in treating inflammatory lesions of rosacea: a randomized, investigator-blinded trial. Br J Dermatol. 172(4):1103-10. PubMed: 25228137
  6. Sbidian E, Vicaut É, Chidiack H, Anselin E, Cribier B, Dréno B, et al. A Randomized-Controlled Trial of Oral Low-Dose Isotretinoin for Difficult-To-Treat Papulopustular Rosacea. J Invest Dermatol. 136(6):1124-1129. PubMed: 26854486